- Differential Diagnosis
Drug Information for HALOPERIDOL TABLETS, USP (Mylan Pharmaceuticals Inc.): DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to HALOPERIDOL TABLETS, USP (Mylan Pharmaceuticals Inc.)
- External Links Related to HALOPERIDOL TABLETS, USP (Mylan Pharmaceuticals Inc.)
Haloperidol is the first of the butyrophenone series of major tranquilizers. The chemical designation is 4-[4-(p-chloro-phenyl)-4-hydroxypiperidino]-4'—fluorobutyrophenone and it has the following structural formula:
Haloperidol is supplied as tablets for oral administration containing 0.5 mg, 1 mg, 2 mg, and 5 mg of haloperidol, and contain the following inactive ingredients: colloidal silicon dioxide, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, pregelatinized starch and sodium lauryl sulfate.
- Drug Information Provided by National Library of Medicine (NLM).